Literature DB >> 1382277

Failure of a second and third generation implantable cardioverter defibrillator to sense ventricular tachycardia: implications for fixed-gain sensing devices.

R E Sperry1, K A Ellenbogen, M A Wood, B S Stambler, J P DiMarco, D E Haines.   

Abstract

Failure to sense ventricular tachycardia and/or ventricular fibrillation by implantable cardioverter defibrillators (ICDs) is rare. We report a case in which persistent undersensing of monomorphic and polymorphic ventricular tachycardia occurred with a second and third generation ICD using fixed-gain sensing. This occurred despite adequate R wave sensing during sinus rhythm. The use of an endocardial sensing lead did not correct the problem. Failure to sense ventricular tachycardia in the third generation device with fixed-gain sensing occurred late after implantation and was discovered only at follow-up electrophysiology testing of the ICD. This problem could not be corrected by reprogramming of the device, and was not related to lead dislodgement. Placement of a new device with an automatic-gain sensing algorithm and use of previously implanted epicardial leads with better sensing characteristics provided appropriate sensing of ventricular tachyarrhythmias. The case illustrates the importance of testing the sensing of all ventricular arrhythmias in patients with fixed-gain ICD's. Follow-up electrophysiology testing and evaluation of epicardial and endocardial leads may be necessary in certain cases to ensure adequate sensing of ventricular tachyarrhythmias late after implantation.

Entities:  

Mesh:

Year:  1992        PMID: 1382277     DOI: 10.1111/j.1540-8159.1992.tb06841.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  1 in total

1.  Assessment of the maximum voltage-guided technique for cavotricuspid isthmus ablation during ongoing atrial flutter.

Authors:  T Bauernfeind; A Kardos; C Foldesi; A Mihalcz; P Abraham; T Szili-Torok
Journal:  J Interv Card Electrophysiol       Date:  2007-09-21       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.